CoChat

Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial

Open access

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

This study aimed to compare conventional medication management of type 2 diabetes (T2D) to medication management in conjunction with a lifestyle intervention using continuous glucose monitoring to minimize glucose excursions. Thirty adults (63% female; mean age, 53.3 years) who were diagnosed with T2D for less than 11 years (mean, 5.6 years), had glycated A1c (HbA1c) ≥ 7.0% (51 mmol/mol) (mean 8.8%, [73 mmol/mol]), and were not using insulin, were randomly assigned in a 1:2 ratio to routine care (RC) or 4 group sessions of glycemic excursion minimization plus real-time CGM (GEMCGM). Assessments at baseline and 5 months included a physical exam, metabolic and lipid panels, a review of diabetes medications, and psychological questionnaires. For the week following assessments, participants wore a blinded activity monitor and completed 3 days of 24-hour dietary recall. A subgroup also wore a blinded CGM. GEMCGM participants significantly improved HbA1c (from 8.9% to 7.6% [74-60 mmol/mol] compared with 8.8% to 8.7% [73-72 mmol/mol] for RC (P = .03). Additionally, GEMCGM reduced the need for diabetes medication (P = .01), reduced carbohydrate consumption (P = .009), and improved diabetes knowledge (P = .001), quality of life (P = .01) and diabetes distress (P = .02), and trended to more empowerment (P = .05) without increasing dietary fat, lipids, or hypoglycemia. Confirming our prior research, GEMCGM appears to be a safe, effective lifestyle intervention option for adults with suboptimally controlled T2D who do not take insulin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jendso/bvaa118

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Timeline of study events. Glycemic excursion minimization plus real-time continuous glucose monitoring (GEMCGM) participants received one 7-day Dexcom G5 sensor at each of the 4 training sessions.
Figure 1. Timeline of study events. Glycemic excursion minimization plus real-time continuous glucose monitoring (GEMCGM) participants received one 7-day Dexcom G5 sensor at each of the 4 training sessions.CC BY · PubMed Central
Figure 2. Means and SDs for glycated hemoglobin (HbA1c), medication effect score (MES), and total treatment effect (TTE) pre to post change scores.
Figure 2. Means and SDs for glycated hemoglobin (HbA1c), medication effect score (MES), and total treatment effect (TTE) pre to post change scores.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 2

  1. Cox, 2018, Continuous glucose monitoring functions as a negative feedback loop for individuals with type 2 diabetes, Ann Diabetes Metab Disorders Control., 1, 121
  2. World Health Organization., 2004, The world health organization quality of life (WHOQOL)-BREF.

Cited by

See all 88

Metadata

Authors
Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., & McCall, A. L.
Affiliations
University of Virginia (US)
Corresponding author
Cox, Daniel J
Venue
Journal of the Endocrine Society
Published
2020-08-18
Volume
4
Issue
11
Pages
bvaa118-bvaa118
ISSN
2472-1972 (ISSN-L)
OpenAlex
W3073688883
Cited by
82
References
15
Citations by year
2026: 19 · 2025: 21 · 2024: 18 · 2023: 8 · 2022: 7 · 2021: 8 · 2020: 1
FWCI
4.53
Type
journal article
Language
en
Open access
Locations
  • Journal of the Endocrine Society (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Dexcom, Inc (IIS-2017-047)
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK108957)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, continuous glucose monitoring, lifestyle intervention, glycemic control, HbA1c, diabetes medication reduction, carbohydrate intake, diabetes knowledge, diabetes distress, quality of life, patient empowerment, non-insulin-treated diabetes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1210/jendso/bvaa118
The paper
Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., & McCall, A. L. (2020). Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial. Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvaa118

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.